Volume 62, Issue 11 pp. 2297-2303
CELLULAR THERAPIES

Relocating to a new facility: The challenge of a cord blood banking transferral in Brazil

Karolyn Sassi Ogliari

Corresponding Author

Karolyn Sassi Ogliari

Hemocord Biotecnologia, Tecnosinos - Technologic Park of São Leopoldo/RS, Brazil

Correspondence

Karolyn Sassi Ogliari, Hemocord Biotecnologia, Av. SAP, 151, Prédio Unitec 3 – Tecnosinos, 93022-718, São Leopoldo/RS, Brazil.

Email: [email protected]

Search for more papers by this author
Fabrizio Blank Loth

Fabrizio Blank Loth

Hemocord Biotecnologia, Tecnosinos - Technologic Park of São Leopoldo/RS, Brazil

Search for more papers by this author
Maria Laura Halon

Maria Laura Halon

Hemocord Biotecnologia, Tecnosinos - Technologic Park of São Leopoldo/RS, Brazil

Search for more papers by this author
Monica Luiza Immig

Monica Luiza Immig

Hemocord Biotecnologia, Tecnosinos - Technologic Park of São Leopoldo/RS, Brazil

Search for more papers by this author
Camila Gomes da Silva

Camila Gomes da Silva

Hemocord Biotecnologia, Tecnosinos - Technologic Park of São Leopoldo/RS, Brazil

Search for more papers by this author
Alícia Sassi Ogliari

Alícia Sassi Ogliari

High School, Panamerican School of Porto Alegre, Porto Alegre/RS, Brazil

Search for more papers by this author
Dário Eduardo De Lima Brum

Dário Eduardo De Lima Brum

Hemocord Biotecnologia, Tecnosinos - Technologic Park of São Leopoldo/RS, Brazil

Search for more papers by this author
Liziane Raquel Beckenkamp

Liziane Raquel Beckenkamp

Hemocord Biotecnologia, Tecnosinos - Technologic Park of São Leopoldo/RS, Brazil

Search for more papers by this author
First published: 17 October 2022

Abstract

Background

Our cord blood banking facility planned and executed a transferral of its entire operation to a new site in the South of Brazil. Transporting LN2 freezers is a complex process in which extensive planning is essential to minimize the risks of damaging products or storage units.

Methods

To fulfill this objective, we constructed a detailed relocation plan consisting of four phases and risk mitigation measures, collaborated with the representatives of all departments, regulating agencies, and professionals from the transport company, and assembled a validation plan for cryogenic freezers and the viability of cord blood units.

Results

The new facility was prepared in accordance with the project plan, local legislation, quality system program requirements, and accreditation agency guidance. A 12-h operation of moving the cryogenic freezers was conducted successfully, with no loss or damage of client samples or equipment.

Conclusion

Through the development and execution of a transferral plan, the engagement of appropriate partners, and compliance with security measures from health and government agencies, a successful transferral of a cord blood banking facility operation in its entirety can be successfully accomplished.

CONFLICT OF INTEREST

Karolyn Sassi Ogliari is a majority shareholder and founder of Hemocord Biotecnologia. The other authors have no conflicts of interest.

DATA AVAILABILITY STATEMENT

Data are available within the article.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.